MiR-299-5p has an opposing role in acute myeloid leukemia (AML) depending on whether or not cytogenetic miR-299-5p is down-regulated in patients with t(11q23)/MLL rearrangement and up-regulated in t(15;17) cytogenetic subtypes [22]. This evidence concerns the gene KMT2A and acute myeloid leukemia.